Developing gammaCore, an FDA-cleared non-invasive vagus nerve stimulation handheld device for the treatment of migraine, cluster headache, and other neurological conditions.
Funding, launches and regulatory moves across the neurotech startup map.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Public
MODALITY
VNS
FORM FACTOR
External device
INTERFACE DEPTH
Non-invasive
INDICATION
Pain/migraine
TARGET USER
Patients
REGULATORY STAGE
FDA cleared (510k)
electroCore is the most commercially advanced non-invasive VNS company, holding the first FDA clearance for neck-based transcutaneous VNS and a broad migraine/cluster headache indication set with reimbursement in some settings. Its public market status and military partnerships give it a distinctive commercial profile in the growing neuromodulation headache space.
%20copy.jpg)
.svg)
